Patents by Inventor Edouard Seche

Edouard Seche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10632182
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.
    Type: Grant
    Filed: May 13, 2015
    Date of Patent: April 28, 2020
    Inventors: Noel Yves Henri Jean Genin, Jean-Christophe Audonnet, Didier Roy, Edouard Seche, Patrick Gervais, Samira Khaldi-Plassart, Romain Useo, Joelle DeConinck
  • Publication number: 20170087230
    Abstract: The present invention relates generally to the fields of immunology and vaccine technology. More specifically, the present invention relates to methods for freeze-drying biological preparations, including peptides, antigens, antibodies, and especially, cells. Importantly, the disclosed methods preserve the viability, infectivity and immunogenicity of cells from the Apicomplexa phylum, the Sarcocystidae family, and in particular, cells from the Toxoplasma genus.
    Type: Application
    Filed: May 13, 2015
    Publication date: March 30, 2017
    Applicants: MERIAL INC., VITAMFERO S.A, L'Universite De Bourgogne, L'Institut National Superieur des Sciences Agronom iques de L'Alimentation et de L'Environment
    Inventors: Noel Yves Henri Jean Genin, Jean-Christophe Audonnet, Didier Roy, Edouard Seche, Patrick Gervais, Samira Khaldi-Plassart, Romain Useo, Joelle DeConinck
  • Patent number: 9603914
    Abstract: A mutant strain of Neospora spp, in which the function of the NcMIC3 protein and/or the function of the NcMIC1 protein is suppressed, and uses thereof in a pharmaceutical composition or in a vaccine composition.
    Type: Grant
    Filed: August 2, 2013
    Date of Patent: March 28, 2017
    Assignee: VITAMFERO
    Inventors: Anne-France Boussemart-Prouvost, Pascal Breton, Mauld Lamarque, Solen Morisse-Philippe, Edouard Seche
  • Patent number: 9585949
    Abstract: Strains of Sarcocystidae selected from Toxoplasma spp or Neospora spp isolated from their natural environment and having an immunostimulant effect, for the use thereof in the prevention or the treatment, in a mammal, of a pathology associated with an apicomplexan of the family Cryptosporidiidae.
    Type: Grant
    Filed: February 4, 2016
    Date of Patent: March 7, 2017
    Assignees: VITAMFERO, INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE, UNIVERSITE FRANCOIS RABELAIS DE TOURS
    Inventors: Audrey Gnahoui-David, Fabrice Laurent, Marie-Noelle Mevelec, Edouard Seche
  • Publication number: 20150190487
    Abstract: A mutant strain of Neospora spp, in which the function of the NcMIC3 protein and/or the function of the NcMIC1 protein is suppressed, and uses thereof in a pharmaceutical composition or in a vaccine composition.
    Type: Application
    Filed: August 2, 2013
    Publication date: July 9, 2015
    Inventors: Anne-France Boussemart-Prouvost, Pascal Breton, Mauld Lamarque, Solen Morisse-Philippe, Edouard Seche
  • Publication number: 20150165008
    Abstract: Strains of Sarcocystidae selected from Toxoplasma spp or Neospora spp isolated from their natural environment and having an immunostimulant effect, for the use thereof in the prevention or the treatment, in a mammal, of a pathology associated with an apicomplexan of the family Cryptosporidiidae.
    Type: Application
    Filed: August 2, 2013
    Publication date: June 18, 2015
    Inventors: Audrey Gnahoui-David, Fabrice Laurent, Marie-Noelle Mevelec, Edouard Seche